BCS Private Wealth Management Inc. Grows Stake in Kenvue Inc. $KVUE

BCS Private Wealth Management Inc. lifted its stake in Kenvue Inc. (NYSE:KVUE) by 379.4% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 68,434 shares of the company’s stock after buying an additional 54,159 shares during the quarter. BCS Private Wealth Management Inc.’s holdings in Kenvue were worth $1,111,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of KVUE. Salomon & Ludwin LLC purchased a new position in shares of Kenvue during the third quarter valued at about $25,000. Trust Co. of Vermont grew its holdings in Kenvue by 266.8% during the 2nd quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock valued at $33,000 after buying an additional 1,150 shares in the last quarter. New England Capital Financial Advisors LLC increased its stake in Kenvue by 81.4% in the 3rd quarter. New England Capital Financial Advisors LLC now owns 2,563 shares of the company’s stock worth $42,000 after acquiring an additional 1,150 shares during the last quarter. First Pacific Financial bought a new stake in Kenvue in the 2nd quarter worth approximately $54,000. Finally, UMB Bank n.a. grew its stake in shares of Kenvue by 22.3% in the 2nd quarter. UMB Bank n.a. now owns 2,853 shares of the company’s stock worth $60,000 after buying an additional 521 shares in the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Kenvue Stock Up 0.7%

Shares of NYSE:KVUE opened at $17.13 on Thursday. The business’s 50 day moving average is $16.95 and its 200 day moving average is $18.32. The stock has a market cap of $32.81 billion, a P/E ratio of 22.83 and a beta of 0.60. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $25.17. The company has a quick ratio of 0.69, a current ratio of 0.98 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last issued its earnings results on Monday, November 3rd. The company reported $0.28 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.01. The business had revenue of $3.76 billion during the quarter, compared to analysts’ expectations of $3.83 billion. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.The business’s revenue for the quarter was down 3.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.28 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Sell-side analysts predict that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, November 26th. Shareholders of record on Wednesday, November 12th were given a dividend of $0.2075 per share. The ex-dividend date of this dividend was Wednesday, November 12th. This represents a $0.83 dividend on an annualized basis and a yield of 4.8%. Kenvue’s dividend payout ratio (DPR) is 110.67%.

Analysts Set New Price Targets

KVUE has been the subject of several analyst reports. Jefferies Financial Group lowered their price objective on Kenvue from $25.00 to $23.00 and set a “buy” rating for the company in a research note on Monday, October 27th. Bank of America decreased their price target on Kenvue from $25.00 to $21.00 and set a “buy” rating on the stock in a report on Wednesday, October 8th. JPMorgan Chase & Co. dropped their price objective on shares of Kenvue from $24.00 to $21.00 and set an “overweight” rating for the company in a research note on Friday, October 10th. Zacks Research upgraded shares of Kenvue from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. Finally, Barclays raised their target price on shares of Kenvue from $17.00 to $18.00 and gave the stock an “equal weight” rating in a report on Monday, November 10th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and twelve have assigned a Hold rating to the stock. According to MarketBeat, Kenvue currently has an average rating of “Hold” and an average price target of $20.23.

Insider Activity at Kenvue

In other Kenvue news, Director Jeffrey C. Smith purchased 3,200,000 shares of the stock in a transaction dated Friday, December 12th. The stock was purchased at an average price of $17.37 per share, with a total value of $55,584,000.00. Following the transaction, the director owned 27,307,632 shares of the company’s stock, valued at approximately $474,333,567.84. This trade represents a 13.27% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 1.68% of the company’s stock.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.